Tonums approach emphasizes oral, research-backed solutions for long-term wellness and avoidance of injection-related harms when injections are not required
There were no sequelae nor complications
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
doi: 10.1016/j.jamda.2019.03.030
Biological Activity In animal models, 5-Amino-1MQ markedly reduces body weight and fat mass, improves insulin sensitivity, and reverses diet-induced hepatic steatosis and adiposity 2,3